2:57 PM · 9 February 2021

Tilray soared in pre-market on medical cannabis agreement

Tilray
Stocks
TLRY.US, Tilray Inc
-
-

Tilray (TLRY.US), a pharmaceutical and cannabis company, gained roughly 20% in pre-market trading as the firm announced it has entered into an agreement with Grow Pharma - the leader in supplying unlicensed cannabis medicines in the UK. Under the agreement, Grow Pharma will distribute Tilray’s medical cannabis products across the United Kingdom. Tilray’s stock price skyrocketed in recent weeks, which might be associated with hopes that Joe Biden could potentially introduce federal marijuana legalisation. 

Tilray (TLRY.US) gained in recent weeks as Biden is expected to support medical cannabis legalisation. Stock price climbed above key area at $22.45 and is expected to open almost 20% higher today. Source: xStation5

10 October 2025, 9:52 AM

DAX: DE40 tries to hold the momentum 📈Brenntag and ArcelorMittal under pressure

9 October 2025, 4:13 PM

Delta Airlines stock lifts off after earnings✈️

9 October 2025, 3:34 PM

Stock of the Week - Super Micro Computer (09.10.2025)

9 October 2025, 3:00 PM

US OPEN: Pepsico and Delta reporting, S&P500 hanging on the top ↔️

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits